Basement membranes are evolutionarily ancient conserved structures that support tissue growth, development, and function. We have previously reported that two basement membrane proteins, Peroxidasin/PXN-2 and F-spondin/SPON-1, are essential for epidermal elongation in C. elegans (Gotenstein, et al. Development. 2010; Woo, et al Development. 2008). We performed large-scale forward genetic screens for suppression of embryonic lethality in
pxn-2 or
spon-1 mutant backgrounds. F-spondins are conserved ECM proteins whose mechanisms remain unclear. Peroxidasins are extracellular peroxidases thought to catalyze sulfilimine cross-linking of collagen IV in the basement membrane (Bhave, et al. Nat Chem Biol. 2012); genetic interactions between collagen IV and
pxn-2 mutants support this role for
pxn-2 in C. elegans. Complete loss of function of PXN-2 causes nonconditional lethality and arrest in late embryogenesis. We report that such
pxn-2 null mutant phenotypes can be suppressed to viability by gain of function mutations in a variety of extracellular matrix or cell-matrix receptor proteins. We identified over 30 suppressors, 12 of which result in missense alterations in the transmembrane protein myotactin/LET-805. The LET-805 extracellular domain contains 36 Fibronectin type III repeats; our suppressor mutations cluster in two pairs of repeats, suggesting these repeats may play a critical role in LET-805 function.
let-805 null mutants are nonconditional embryonic lethal, whereas our suppressors are viable and display no obvious phenotypes other than suppression. Localization of a LET-805::GFP knockin is essentially normal in the suppressor alleles, suggesting they have a subtle effect on LET-805 expression.
let-805 suppressor alleles partially suppress lethality in loss of function but not null mutations in other basement membrane components, but do not suppress loss of function in intracellular epidermal cytoskeletal components.
pxn-2 mutants have defects in locomotion that are not suppressed by
let-805, and we will report our analysis of this possible neural role for PXN-2. . In summary, our results reveal novel compensatory mechanisms in basement membrane receptor complexes that allow key structural or enzymatic components to be bypassed.